NCI to Fund Development of Predictive Models for Cancer Risk, Prognosis | GenomeWeb

NEW YORK (GenomeWeb News) – The National Cancer Institute seeks to fund researchers who will conduct innovative work aimed at developing or improving models for assessing cancer risk and prognosis.

These research programs could include studies to identify or validate protein biomarkers or genetic variants that could be used to develop the prediction models, according to a recently published program announcement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.